GBGilchrist Abdoul Laurent Boly

Gilchrist Abdoul Laurent Boly

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gilchrist Abdoul Laurent Boly has a total of 41 co-authors. Here are the top co-authors by number of shared publications:

  • Aristide Traore

    Laboratoire de Recherche-Développement de Phytomédicaments et Médicaments (LR-D/PM), Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), Ouagadougou 03 BP 7047, Burkina Faso

    2 shared publications
  • Do Harouna Dao

    Laboratoire de Recherche-Développement de Phytomédicaments et Médicaments (LR-D/PM), Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), Ouagadougou 03 BP 7047, Burkina Faso

    2 shared publications
  • Estelle Noëla Hoho Youl

    Laboratoire de Développement du Médicament (LADME), Centre de Formation, de Recherche et d’Expertises en Sciences du Médicament (CEA-CFOREM), École Doctorale Sciences de la Santé (ED2S), Université Joseph KI-ZERBO, Ouagadougou 03 BP 7021, Burkina Faso

    2 shared publications
  • Félix Bondo Kini

    Department de Médecine et Pharmacopée Traditionnelles/Pharmacie (MEPHATRA/Ph), Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), Ouagadougou 03 BP 7192, Burkina Faso

    2 shared publications
  • Jean Claude Romaric Pingdwindé Ouédraogo

    Institute of Health Sciences Research (IRSS)

    2 shared publications
  • Jonas Tiami Coulibaly

    Laboratoire de Recherche-Développement de Phytomédicaments et Médicaments (LR-D/PM), Institut de Recherche en Sciences de la Santé (IRSS), Centre National de la Recherche Scientifique et Technologique (CNRST), Ouagadougou 03 BP 7047, Burkina Faso

    2 shared publications

Latest Publications

  • Open Access

    Optimization and Standardization of the Extraction Method of Balanites aegyptiaca Del. Seeds (Zygophyllaceae) Used in the Formulation of an Antiparasitic Phytomedicine

    by Mohamed Bonewendé Belemlilga, Salfo Ouedraogo, Gilchrist Abdoul Laurent Boly, Do Harouna Dao, Jonas Tiami Coulibaly, Jean Claude Romaric Pingdwindé Ouedraogo, Souleymane Compaoré, Sidiki Traore, Moumouni Koala, Estelle Noëla Hoho Youl, et al.

    Background/Objectives: Balanites aegyptiaca Del. (Zygophyllaceae) is widely used in traditional medicine, both human and veterinary, throughout Africa for its many properties, including antiparasitic properties. This experimental study aims to optimize the extraction conditions of the seeds of Balanites aegyptiaca Del. Methods: Aqueous maceration was carried out with mass-to-volume ratios of 40%, 30%, 20%, 10% and 5% and extraction times of 6, 12, 24, 36 and 48 h. Extraction yields, phytochemical screening, saponins assay, antioxidant activities ABTS+ free radical scavenging activities, Ferric-reducing antioxidant power (FRAP) assay and antiparasitic tests on Heligmosomoides bakeri were used to compare the different extracts. Results: The pharmaco-chemical study generally showed that aqueous maceration gave the best results, with a mass/volume ratio of 10% after 12 h of maceration. The yield obtained was 28.03% with a saponins content of 13.81 mg/g. The antioxidant activities were 4.25 ± 0.17 µg/mL by the ABTS method and 0.739 µg/mL by the FRAP method. The larvicidal activity also showed that the 10% 12 h extract produced 100% larval mortality from 25 µg/mL. Conclusions: These data provide a basis for guiding the extraction process parameters in producing this antiparasitic phytomedicine.


  • Open Access

    Cytotoxic and Anti-inflammatory Properties of Two Medicinal Plant Recipes Decoctions, acphyx and chryfa, Used in Traditional Medicine of Burkina Faso

    by Boly Abdoul Gilchrist Laurent, Bayala Bagora, Kaboré Sergine, Belemlilga Bonewendé Mohamed, Ouédraogo Annick Madinatou, Yaro Boubacar, Yabre Zacqueline, Koala Moumouni, Ilboudo Dénise, Sombié Charles, et al.

    Aims: Cancer is a major public health problem worldwide and in Burkina Faso. This study aimed to evaluate the cytotoxic and anti-inflammatory properties of ACPHYX and CHRYFA, two medicinal plant recipes used against inflammatory diseases in traditional medicine in Burkina Faso. Study Design: The anti-inflammatory and anti-proliferative activity on prostate and cervical cancer cells of a recipe orients on its possible anti-cancer properties. Then would help to realize ethnopharmacological evidence study for its validation or not as a phytomedicine against prostate or cervical cancer. Place and Duration of Study: The studies were carried out in the laboratories of the Pietro Anignoni Biomolecular Research Center (CERBA) and the Health Sciences Research Institute (IRSS/CNRST) from December 2021 to March 2023 in Burkina Faso. Methodology: An aqueous decoction of ACPHYX recipe and CHRYFA recipe, were made. The phytochemical groups of interest and the phenolic compound content of the extracts were determined. The antioxidant test was performed by the DPPH and FRAP methods. The cytotoxic activity on cancer cells was evaluated by the MTT test. Anti-inflammatory activity was assessed by pro-inflammatory enzyme inhibition tests (15-lipoxygenase, cyclooxygenases), anti-edema and antihistamine tests. Results: ACPHYX decoction showed the best antioxidant activity by DPPH method (IC50 of 12.80 ± 0.5μg/mL). The chelation capacity evaluated by FRAP method was also better with ACPHYX decoction (1.94 ± 0.296 mmol EAA/g). ACPHYX decoction also showed the best cytotoxic activity on prostate cancer DU145 cells (175.5 ± 3.79 μg/mL) and cervical cancer HeLa cells (302.5 ± 64.36 μg/mL). In vitro, the extracts inhibited 60% edema at 400 mg/kg dose and 79.32% scratching inhibition at 600 mg/kg dose. Conclusion: The strongest anti-inflammatory activity in vitro and in vivo was observed with ACPHYX extract. ACPHYX recipe compared to CHRYFA showed better cytotoxic and anti-inflammatory properties. Its use could help to treat tumor and inflammatory conditions through further studies.

  • Open Access

    Optimisation and Standardisation of the Extraction Method of Balanites aegyptiaca Del. Seeds (Zygophyllaceae) Used to Formulate a Phytomedicine

    by Mohamed Bonewendé Belemlilga, Salfo Ouedraogo, Gilchrist Abdoul Laurent Boly, Do Harouna Dao, Jonas Tiami Coulibaly, Jean Claude Romaric Pingdwindé Ouedraogo, Souleymane Compaoré, Sidiki Traore, Moumouni Koala, Estelle Noëla Hoho Youl, et al.

    Balanites aegyptiaca del. (Zygophyllaceae) is widely used in traditional medicine, both human and veterinary, throughout Africa for its many properties, including antiparasitic properties. This experimental study aims to optimise the extraction conditions of the seeds of Balanites aegyptiaca del. Aqueous maceration was carried out with mass to volume ratios of 40%, 30%, 20%, 10% and 5% and extraction times of 6, 12, 24, 36 and 48 hours. Extraction yields, phytochemical screening, saponins assay, antioxidant activities (ABTS and FRAP) and antiparasitic tests on Heligmosomoides bakeri were used to compare the different extracts. The pharmaco-chemical study generally showed that aqueous maceration gave the best results, with a mass/volume ratio of 10% after 12 hours of maceration. The yield obtained was 28.03% with a saponins content of 13.81 mg/g. The antioxidant activities were 4.25 ± 0.17µg/mL by the ABTS method and 0.739µg/mL by the FRAP method. The larvicidal activity also showed that the 10%12h extract produced 100% larval mortality from 25ug/mL. These data provide a basis for guiding the choice of extraction process parameters in producing this antiparasitic phytomedicine.

  • Open Access

    Influence of Particle Size on the Phytochemical, Antioxidant and Anti-Inflammatory Properties of Powder of Trunk Bark Parkia biglobosa (JACQ) (Fabaceae-Mimosadeae)

    by Boly A. G. Laurent, Boly Rainatou, Atchadé C. Boladé, Belem-Kabré W. L. M. Esther, Traore K. Tata, Ouattara S. W. Norbert, Ouedraogo Salfo, Youl E. H. Noëla, Ouedraogo Noufou

    Aims: The present study aim was to evaluate influence of particle size on the phytochemical, antioxidant and anti-inflammatory properties of powder of trunk bark Parkia biglobosa. Study Design:  This is an experimental study Place and Duration of Study: The study was realized in the Phytomedicine and Medicine Research-Development (LR-D/PM) laboratories of the Health Sciences Research Institute (IRSS) of Ouagadougou in Burkina Faso. Methodology: The powder was sieved and classified into four particle sizes: coarse, moderately fine, fine, and very fine. An aqueous decoction was then made from these powders. The extraction yields, qualitative phytochemical composition, and the estimation of polyphenol compound content were determined. The antioxidant effect of the extracts was obtained using four antioxidant models: ABTS, DPPH, FRAP, and LPO. The anti-inflammatory activity was evaluated against the soybean 15-lipoxygenase. Results: Decreasing the particle size from coarse to very fine resulted in an approximately two-fold increase in extraction yield (from 12.19 to 29.05); an approximately two-fold increase in antioxidant and anti-inflammatory activities: ABTS (from 4.1 ± 0.1 to 1.4 ± 0.3 µg/mL); DPPH (from 7.3 ± 0.1 to 3.1 ± 0.3 µg/mL); FRAP (from 885.6 ± 84 to 6973 ± 21 mmol EAA/g), and LOX (from 34.09 ± 1.43 to 2.88 ± 0.65 µg/mL). Moreover, the modification of the particle size has also improved the LPO inhibitory activity and total phenolic and flavonoid contents. The increased surface area in contact with the extraction solvent may explain the interesting effect of the very fine powder Conclusion: The very fine powder offers more significant antioxidant and anti-inflammatory activities. Therefore, this powder can be suggested to develop a phytomedicine against inflammatory diseases